Richard Ellison to Anti-Bacterial Agents
This is a "connection" page, showing publications Richard Ellison has written about Anti-Bacterial Agents.
Connection Strength
0.592
-
Lilly CM, Ellison RT. Quality measures for critically ill patients: where does ventilator-associated condition fit in? Chest. 2013 Nov; 144(5):1429-1430.
Score: 0.293
-
Daly JS, Giehl TJ, Brown NC, Zhi C, Wright GE, Ellison RT. In vitro antimicrobial activities of novel anilinouracils which selectively inhibit DNA polymerase III of gram-positive bacteria. Antimicrob Agents Chemother. 2000 Aug; 44(8):2217-21.
Score: 0.117
-
Ellison RT. The effects of lactoferrin on gram-negative bacteria. Adv Exp Med Biol. 1994; 357:71-90.
Score: 0.074
-
Zivna I, Bergin D, Casavant J, Fontecchio S, Nelson S, Kelley A, Mathis S, Melvin Z, Erlichman R, Ellison RT. Impact of Bordetella pertussis exposures on a Massachusetts tertiary care medical system. Infect Control Hosp Epidemiol. 2007 Jun; 28(6):708-12.
Score: 0.047
-
Ellison RT, Boose D, LaForce FM. Isolation of an antibacterial peptide from human lung lavage fluid. J Infect Dis. 1985 Jun; 151(6):1123-9.
Score: 0.041
-
Proulx MK, Palace SG, Gandra S, Torres B, Weir S, Stiles T, Ellison RT, Goguen JD. Reversion From Methicillin Susceptibility to Methicillin Resistance in Staphylococcus aureus During Treatment of Bacteremia. J Infect Dis. 2016 Mar 15; 213(6):1041-8.
Score: 0.021